India’s HPV Vaccine Drive: Lakhs Immunized in One Month

India’s HPV Vaccine Drive: Lakhs Immunized in One Month

India’s recent HPV vaccination drive represents a massive leap in preventive oncology for the nation. The Union Health Ministry reported successful early progress on Tuesday regarding this public health initiative. This campaign targets millions of adolescent girls to reduce the long-term cervical cancer burden. Since the official rollout, healthcare providers have successfully immunised lakhs of eligible candidates across various states.

Current Progress of the HPV Vaccination Drive

Launched on February 28, 2026, the national campaign targets approximately 1.2 crore girls. Specifically, it focuses on 14-year-old beneficiaries across all States and Union Territories. The programme currently uses the single-dose Gardasil-4 quadrivalent vaccine to provide protection. Furthermore, the government provides this vaccine free of cost at public health facilities. These sites include Primary Health Centres, Community Health Centres, and District Hospitals. Such widespread availability ensures last-mile access for rural and underserved populations. Consequently, the government aims to achieve high coverage within the first few months.

Safety Protocols and Clinical Supervision

The HPV vaccination drive operates under strict medical supervision to ensure maximum safety for all girls. Every vaccination site remains linked to 24×7 Adverse Events Following Immunization (AEFI) management centres. These specialized centres provide prompt management for any potential adverse reactions. However, the programme remains entirely voluntary for all eligible participants. Parents must provide mandatory written consent before their child receives the vaccine dose. This ethical approach helps build community trust and encourages long-term vaccine acceptance. Moreover, trained medical officers oversee every session to maintain high clinical standards.

Long-term Strategy for Cervical Cancer Elimination

The initial intensive campaign will last for a period of three months across the country. Afterward, the vaccine will integrate seamlessly into routine immunisation services. This transition ensures sustained coverage for all future cohorts of eligible girls. Additionally, India has adopted a multi-faceted strategy to eliminate cervical cancer entirely. This comprehensive plan combines vaccination with periodic screening and early diagnosis. Therefore, health officials expect a significant reduction in disease mortality among women nationwide. Strengthening preventive healthcare remains a top priority for the current administration. Professionals seeking to advance their skills in cancer prevention can explore options in Clinical Oncology.

Frequently Asked Questions

Q1: Who is eligible for the free HPV vaccine under this programme?

Currently, the nationwide campaign targets 14-year-old girls across all States and Union Territories. Some specific campaign guidelines may also include girls who turn 15 within the 90-day intensive phase.

Q2: Is the vaccine mandatory for school-going girls in India?

No, the vaccination remains completely voluntary. Parental consent is a mandatory requirement before any child receives the vaccine at a government facility.

Q3: Which specific vaccine is being administered by the government?

The government is currently administering the single-dose Gardasil-4 vaccine. This quadrivalent shot protects against HPV types 6, 11, 16, and 18, which are major causes of cervical cancer and warts.

References

1. India’s HPV Vaccination Drive Gains Momentum, Lakhs of Girls Covered in firstmonth – ETHealthworld
2. PIB Delhi. (2026, March 17). Update on National HPV Vaccination Programme.
3. India Today. (2026, February 25). India to provide free HPV vaccines: Science explained.

Disclaimer: This article was automatically generated from publicly available sources and is provided for informational and educational purposes only. OC Academy does not exercise editorial control or claim authorship over this content. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider and refer to current local and national clinical guidelines.